Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs Vitamin C with Microneedling for Periorbital Hyperpigmentation
NCT04697992Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Nov 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of tranexamic acid in periorbital hyperpigmentation (POH) (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoints: Clinical Grading of Periorbital Hyperpigmentation at 10 weeks, Dermoscopic Evaluation of Pigmentary and Vascular Components at 10 weeks and 3 more. Started Nov 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
periorbital hyperpigmentation (POH)
Beyond the preview
Go deeper on NCT04697992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04697992.